TBPN cover image

Novartis Buys Excellergy for $2B, Anthropic Vs. Pentagon, The Mansion Section | Diet TBPN

TBPN

00:00

A proven CEO repeats the formula

John Coogan breaks down Accelergy’s allergy-drug science, funding path, phase one progress, and the repeat-success record of CEO Todd Zavodnik.

Play episode from 03:21
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app